Abstract: The high-resolution NMR structure of the N-domain of human eRF1, responsible for stop codon recognition, has been determined in solution. The overall fold of the protein is the same as that found in the crystal structure. However, the structures of several loops, including those participating in stop codon decoding, are different. Analysis of the NMR relaxation data reveals that most of the regions with the highest structural discrepancy between the solution and solid states undergo internal motions on the ps-ns and ms time scales. The NMR data show that the Ndomain of human eRF1 exists in two conformational states. The distribution of the residues having the largest chemical shift differences between the two forms indicates that helices a2 and a3, with Abbreviations: CBCA(CO)NH, 3D experiment correlating the amide NH with the Ca and Cb signals of the preceding amino acid; CeRF1 or C-domain, C-terminal domain (or domain 3) of class-1 polypeptide chain release factor; eRF1, eukaryotic class-1 polypeptide chain release factor; eRF3, eukaryotic class-2 polypeptide chain release factor 3; HNCACB, 3D experiment correlating the amide NH with the Ca and Cb signals; HNCO, 3D experiment correlating the amide NH with the C 0 signal of the preceding amino acid; HSQC, heteronuclear single quantum coherence spectroscopy; M-eRF1 or M-domain, eRF1 middle domain (or domain 2); N-eRF1 or N-domain, N-terminal domain (or domain 1) of class-1 polypeptide chain release factor; NOE, nuclear Overhauser effect; NOESY, nuclear Overhauser enhancement spectroscopy; RDC, residual dipolar coupling; R 1 , longitudinal or spin-lattice relaxation rate; R 2 , transverse or spin-spin relaxation rate; R ex , conformational exchange contribution to R 2 ; RF, release factor; RMSD, root-meansquare deviation; S 2 , order parameter reflecting the amplitude of ps-ns bond vector dynamics.
Abstract: The high-resolution NMR structure of the N-domain of human eRF1, responsible for stop codon recognition, has been determined in solution. The overall fold of the protein is the same as that found in the crystal structure. However, the structures of several loops, including those participating in stop codon decoding, are different. Analysis of the NMR relaxation data reveals that most of the regions with the highest structural discrepancy between the solution and solid states undergo internal motions on the ps-ns and ms time scales. The NMR data show that the Ndomain of human eRF1 exists in two conformational states. The distribution of the residues having the largest chemical shift differences between the two forms indicates that helices a2 and a3, with Abbreviations: CBCA(CO)NH, 3D experiment correlating the amide NH with the Ca and Cb signals of the preceding amino acid; CeRF1 or C-domain, C-terminal domain (or domain 3) of class-1 polypeptide chain release factor; eRF1, eukaryotic class-1 polypeptide chain release factor; eRF3, eukaryotic class-2 polypeptide chain release factor 3; HNCACB, 3D experiment correlating the amide NH with the Ca and Cb signals; HNCO, 3D experiment correlating the amide NH with the C 0 signal of the preceding amino acid; HSQC, heteronuclear single quantum coherence spectroscopy; M-eRF1 or M-domain, eRF1 middle domain (or domain 2); N-eRF1 or N-domain, N-terminal domain (or domain 1) of class-1 polypeptide chain release factor; NOE, nuclear Overhauser effect; NOESY, nuclear Overhauser enhancement spectroscopy; RDC, residual dipolar coupling; R 1 , longitudinal or spin-lattice relaxation rate; R 2 , transverse or spin-spin relaxation rate; R ex , conformational exchange contribution to R 2 ; RF, release factor; RMSD, root-meansquare deviation; S
Introduction
The molecular mechanism of translation is the focus of intensive studies. While most aspects of this complex process have been explored in detail, the mechanism of termination still has several unanswered questions. The mechanism of stop codon recognition by the class 1 eukaryotic release factor eRF1 is one of such issues (reviewed in Refs. 1 and 2). It has been determined that the prokaryotic release factors, RF1 and RF2, recognize pairs of stop codons (UAG/ UAA and UGA/UAA, respectively) through interactions with the so-called tripeptide ''anticodon'' regions of mRNA. [3] [4] [5] [6] In contrast to their prokaryotic analogues, the eukaryotic termination factor, eRF1, from organisms using the universal genetic code is equally able to recognize all three stop codons (reviewed in Ref. 7) . The crystal structure of eRF1 8, 9 shows that the protein contains three spatially separated domains (the N-, M-, and C-domains). Functional analysis of eRF1 10 has suggested that the N-terminal domain is involved in stop codon recognition. More recently, the role of the N-domain has been confirmed unambiguously: chimeric eRF1s, in which the N-and MCdomains were derived from variant-code ciliate organisms 11, 12 and human/yeast eRF1, respectively, exhibit ciliate stop codon decoding specificity in vitro. [13] [14] [15] [16] Several hypotheses for the molecular mechanism of stop codon recognition by eRF1 have been suggested, 9, [17] [18] [19] [20] [21] [22] [23] but none satisfactorily explain the available experimental data which are somewhat contradictory. High-quality structural information is essential for understanding the nature of the mRNA-eRF1 interaction. However, atomic resolution data for eukaryotic termination complexes are unavailable; and the quality of the eRF1 crystal structures 8,9 also leaves something to be desired, as several regions of the protein are ill-defined. Previously we determined the structure of the middle (M) and C-terminal domains of human eRF1 in solution. 24, 25 Fig. S1 ). This indicates the presence of at least two conformational states of the protein.
Structure determination. A family of 20 NMR structures was determined on the basis of 3092 experimental restraints measured at 298 K (see Table  I and Supporting Information Fig. S2 ). The statistics of the final ensemble are given in Table I and the superposition of the final calculated family is presented in Figure 1 (A) (the backbone atoms of the Ndomain of the human eRF1 crystal structure 8 are also shown in red for comparison). The RMSD of the calculated family from the representative structure is less than 0.5 Å for the backbone heavy atoms of the residues 6-142. In the Ramachandran plot analysis (Supporting Information Fig. S3 ), 93.3% of the residues in the whole NMR family were found in the most favored regions and none in the disallowed regions.
Backbone dynamics. Supporting Information Figure S4 presents the experimentally obtained relaxation rates R 1 and R 2 and NOE values for the amide 15 N nuclei measured at 298 K, the calculated values of the order parameter S 2 and the conformational exchange contributions to the transverse relaxation rates R ex . The relaxation parameters were obtained using a model with an axially symmetric diffusion tensor. The order parameter is smallest for the Nand C-terminal residues and also for the residues in several loops (30-33, 64, 106-108, 122-123) . This indicates the regions in the structure where there is the highest amplitude of internal motions. The average correlation time (1/(2D k þ 4D ? ) was 11.04 6 0.16 ns and the ratio of the principal axis of the tensor (D k /D ? ) was 1.6 6 0.1. The best model that allows the most successful fit of the experimental data is that based on two internal motions with correlation times of 1.05 6 0.05 ns and <50 ps (Supporting Information Fig. S5 ).
Comparison of the crystal and solution structures. The topology of the N-domain of human eRF1 can be described as a b-sheet core formed from four anti-parallel b-strands, surrounded by four helices, a1-a4 [ Fig. 1(B) ]. There are also a number of loops of differing lengths, some of which are reported to be involved in stop codon recognition. For example, the loop between helices a2 and a3 contains conserved NIKS tetrapeptide. The overall fold of the N-domain of human eRF1 is the same in the crystal and solution structures but the detailed structures are far from identical [ Fig. 1(A) ]. The RMSD of the superposition of the heavy backbone atoms (Ca, N, O, and C 0 ) of the family of 20 NMR structures onto the crystal structure of the N-domain is 1.8 6 0.1 Å .
To identify the goodness of fit of the solution and crystal structures and the regions of the maximum displacement, local RMSD values q i 27 were calculated for local pairwise superposition of the two structures (Supporting Information Fig. S6 ). The thickness of the ribbon [shown in Fig. 1(C) ] is proportional to the q i values, which reflects the degree of divergence of the local protein backbone geometry in the two structures.
Minor protein conformer. Signals from several amino acids of the N-domain of human eRF1 are observed in NMR spectra as double peaks, representing major (80-90%) and minor (10-20%) components. The assignment of the minor conformer peaks is based on the characteristic cross peaks in the 3D heteronuclear spectra, including the NOESY spectra. Supporting Information Fig S1 illustrates the two sets of signals in the 15 N-1 H HSQC spectrum of the protein backbone and side chain amide groups.
Discussion
A comparison of the structure of the N-domain in solution and in the crystal showed that its N-and C-termini and most of the protein loops show clear differences in their backbone conformations. This can either be due to real structural differences between the protein in the crystal and in solution or to the absence of the neighboring M-and C-domains in the structure solved by NMR. It is likely that the differences in the protein conformation of loop 115- 123 (having the largest RMSD values, Fig. 1(C) , Supporting Information Fig S4B) and the C terminus originate from the absence of the neighboring M-and C-domains in the solution structure. The changes in residues 41-42 and 89-91 are likely to be secondary effects caused by the conformational change of loop 115-123. However, loops 29-33, 61-64, and 101-105 [ Fig. 1(C) ] are all far from both Mand C-domains and therefore their large structural displacement is very likely to reflect real conformational differences between the crystal and solution states. It should be noted that loop 61-64 contains the conserved NIKS tetrapeptide sequence which is thought to be involved in the recognition of the The ability of human eRF1 to recognize each of the three stop codons UAA, UAG, and UGA and to distinguish them from the UGG tryptophan codon cannot be explained in terms of a simple static interaction. 30 It is obvious that the N-domain of human eRF1 should be able to undergo conformational rearrangements -not only in solution but also inside the ribosome. Therefore the elucidation of the dynamic properties of this protein is crucial for understanding the mechanism of stop codon recognition. Modelfree analysis of the relaxation data shows that there are several protein regions that undergo backbone motions with a correlation time of about 1 ns. Among these are residues 30-31, 64, and 122-123. Several other residues (45, 54-57, 63, 67, 134-135) were found to undergo conformational rearrangements on the ms time scale. These results are summarized in Figure 2 (A), where residues undergoing fast (ns) motions are shown as yellow and those involved in slower (ms) motions are shown in red. It can be seen that two helices (a2 and a3), with NIKS loop between them, and two other loops (29-33 and 101-105) have high conformational plasticity. These protein regions are likely to be involved in stop codon recognition, either by their direct interaction with mRNA or by induced conformational rearrangements from the recognition sites.
Interesting information can also be obtained from an analysis of the residues which have duplicated signals in the NMR spectra and their distribution within the structure [ Fig. 2(B) ]. The duplication indicates that the protein exists in two conformational states with a ratio of the major to minor forms of about 5:1. Those residues which have large chemical shift differences between the two forms should be close to the center of the conformational rearrangement. Most of these residues are located at the interface between the b-sheet core of the protein and helices a2 and a3. Their distribution [ Fig. 2(B) ] hints at a possible conformational rearrangement. This could be due to a change of helix orientation against the bundle of b-strands. For example, the chemical shifts of the side chain of Asn111 are substantially different between the major and minor protein conformations. It is very likely that residue Asn111, which is isolated in the major form, becomes close to the helix a3 in the minor form.
It is of interest and possible mechanistic importance that the location of the highest amplitude internal motions, the residues from the GTS and NIKS loops of eRF1, coincide with the published experimental data suggesting that amino acids in these regions of the N-domain of eRF1 are essential for stop codon decoding.
Materials and Methods
Sample preparation. The DNA fragment encoding the N-domain of human eRF1 (residues 1-142) with a C-terminal His 6 -tag fusion was cloned into the pET23b(þ) vector (Novagen) under the phage T7 RNA polymerase promoter. N-eRF1 was overproduced in E. coli, strain BL21(DE3), in M9 minimal medium and isolated using Ni-NTA resin (Qiagen). 1 H, 15 N] NOESY spectra measured at 298 K with a 100 ms mixing time. NOE peak volumes were calculated using the Sparky software. 32 The structure calculations and refinement were made by a simulated annealing protocol carried out in Cartesian coordinate space using CNS. 40 The restraint violations were monitored after each cycle of refinement by the NMRest program. 24 2631 NOEderived distance restraints, 316 dihedral angles, and 69 RDCs were used in the calculation of the final ensemble (see Supporting Information Table S1 ).
The structure quality has been analyzed with the AQUA and Procheck-NMR software 41 (Supporting Information Fig. S3 ). 
